Group One Trading, L.P. Fate Therapeutics Inc Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 2,117 shares of FATE stock, worth $3,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,117
Holding current value
$3,514
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.12 - $5.57 $6,605 - $11,791
2,117 New
2,117 $7,000
Q1 2024

May 10, 2024
SELL
$3.54 - $8.35 $55,362 - $130,585
-15,639 Reduced 93.71%
1,050 $7,000
Q4 2023

Feb 14, 2024
BUY
$1.65 - $3.94 $17,160 - $40,976
10,400 Added 165.37%
16,689 $62,000
Q3 2023

Nov 09, 2023
BUY
$2.02 - $5.04 $12,703 - $31,696
6,289 New
6,289 $13,000
Q4 2022

Feb 09, 2023
BUY
$9.86 - $23.83 $4,131 - $9,984
419 Added 18.75%
2,654 $26,000
Q3 2022

Nov 09, 2022
SELL
$21.04 - $36.06 $193,589 - $331,788
-9,201 Reduced 80.46%
2,235 $50,000
Q2 2022

Aug 11, 2022
BUY
$17.78 - $42.39 $92,456 - $220,428
5,200 Added 83.39%
11,436 $283,000
Q1 2022

May 12, 2022
BUY
$29.67 - $60.28 $185,022 - $375,906
6,236 New
6,236 $242,000
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $321,658 - $519,526
-5,427 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$67.25 - $92.52 $364,965 - $502,106
5,427 New
5,427 $471,000
Q4 2020

Feb 10, 2021
SELL
$38.09 - $100.95 $64,410 - $170,706
-1,691 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$30.41 - $40.5 $163,392 - $217,606
-5,373 Reduced 76.06%
1,691 $68,000
Q2 2020

Aug 13, 2020
SELL
$20.21 - $35.23 $389,204 - $678,459
-19,258 Reduced 73.16%
7,064 $242,000
Q1 2020

May 13, 2020
BUY
$17.28 - $31.88 $410,054 - $756,512
23,730 Added 915.51%
26,322 $585,000
Q4 2019

Feb 10, 2020
BUY
$13.39 - $20.73 $31,171 - $48,259
2,328 Added 881.82%
2,592 $51,000
Q3 2019

Nov 12, 2019
SELL
$15.47 - $22.5 $18,564 - $27,000
-1,200 Reduced 81.97%
264 $4,000
Q2 2019

Aug 09, 2019
SELL
$15.61 - $20.44 $45,269 - $59,276
-2,900 Reduced 66.45%
1,464 $30,000
Q1 2019

May 13, 2019
SELL
$13.15 - $18.71 $44,197 - $62,884
-3,361 Reduced 43.51%
4,364 $77,000
Q4 2018

Feb 06, 2019
BUY
$11.48 - $16.98 $88,683 - $131,170
7,725 New
7,725 $99,000
Q3 2018

Nov 08, 2018
SELL
$8.75 - $16.29 $203,980 - $379,752
-23,312 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $213,537 - $314,245
23,312 New
23,312 $264,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email